Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
118 participants
INTERVENTIONAL
2004-09-30
2006-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Yoga, one hour class, 3 times per week, for 24 weeks
Yoga, one hour class, 3 times per week, for 24 weeks
Yoga, one hour class, 3 times per week, for 24 weeks
2
Luncheon Seminar Series, once per month, for 24 weeks
Luncheon Seminar Series, once per month, for 24 weeks
Luncheon Seminar Series, once per month, for 24 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Yoga, one hour class, 3 times per week, for 24 weeks
Yoga, one hour class, 3 times per week, for 24 weeks
Luncheon Seminar Series, once per month, for 24 weeks
Luncheon Seminar Series, once per month, for 24 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* willingness to accept randomization
* adult-onset hyperkyphosis (noticed after age 50)
* measured Debrunner kyphometer angle \>40 degrees
Exclusion Criteria
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Geffen SOM at UCLA
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gail A Greendale, MD
Role: PRINCIPAL_INVESTIGATOR
University of California, Los Angeles
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCLA Division of Geriatrics
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.